Guest guest Posted April 25, 2011 Report Share Posted April 25, 2011 Hi That is a good question, and one I dont think anyone knows the true answer to. We have all chatted about this topic before. Chronic Hepatitis B and C cases are all included in the number 1 in 12 that you hear so much about. I have read many conflicting reports that contain numbers, but who really knows what the truth is? Some countrys and regions in Africa, for example, are not monitored. WHO [World Health Org] is probably the most extensive [covering most countrys], and even their internal numbers conflict. Here is a shocker - supposively 80% of Egyptians have Chronic Hepatitis [not sure if that is B, C, or both]. - [i dont know how anyone came up with that number. It seems quite high to me.] In the USA and Canada its somewhere around 1-1/2% to 3%. - [Many people dont know that they are infected due to no symptoms, so the numbers could be much higher.] Europian countrys are a bit higher, but I have read that most liver disease in Europe is from Alcohol use, not Hepatitis, altho those numbers are rising also. I could provide you links to articles, but they will be inconclusive and contridictory. I have read that Chronic Hepatitis is concidered to be a PANDEMIC. love don in ks News 5 new results for hepatitis c On the long, hard road to a breakthroughBoston Globe(Josh Reynolds for The Boston Globe) By Carolyn Y. CAMBRIDGE — Fifteen years ago, Boger received a call from a team of scientists one floor down at Vertex Pharmaceuticals Inc. who were searching for the key to hepatitis C, ...See all stories on this topic » Boston Globe Asia's problem with chronic hepatitisExaminer.comThese viruses constitute a major global health risk with around 350 million people being chronically infected with hepatitis B and around 170 million people being chronically infected with hepatitis C. According to the CDC, Hepatitis B is a contagious ...See all stories on this topic » Rearranging the Corporate DNABoston GlobeApproval for telaprevir — a drug aimed at curing hepatitis C — would hasten Vertex's transition from a research and development company that invested some $4 billion in drug discovery over the past two decades to an integrated research and commercial ...See all stories on this topic » Now comes the hard part: marketing an unknownBoston GlobeHe does admit it was a gamble to trade Merck & Co. for Vertex — and uproot his family — before telaprevir, Vertex's potential blockbuster drug to treat hepatitis C, has won approval from regulators. “There's some risk from a career perspective,'' ...See all stories on this topic » As science turns from chimp research, US wants to restart itKansas City StarCalling chimps crucial to advancing hepatitis C research, the NIH wants to ship them from the facility in New Mexico to the Texas Biomedical Research Institute in San . The director of the Texas institute's primate facility called chimps "a ...See all stories on this topic » Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.